MedPath

Examination about the influence that DPP-4 inhibitor gives for a left ventricle function in acute myocardial infarctio

Not Applicable
Recruiting
Conditions
acute myocardial infarction, type2 diabetes mellitus
Registration Number
JPRN-UMIN000014539
Lead Sponsor
Center for Cardiovascular Interventions,Chiba University Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
38
Inclusion Criteria

Not provided

Exclusion Criteria

1) Severe renal disease or dialysis patient 2) Insulin-dependent patient (CPR index <0.8) 3) Patient of type I diabetes mellitus 4) The patient who uses DPP-4 inhibitor, GLP-1 preparation in either from three months ago before hospitalization to the hospitalization direct front 5) Patient having a serious liver disease 6) Patient with the possibility of the pregnancy or the pregnancy, the patient whom I am nursing 7) Patient having a side effect for DPP-4 inhibitor, antiplatelet and the anticoagulant 8) The patient who develops lower limbs confinement-related arteriosclerosis having severe lower limbs ischemia 9) Patient having heart failure of NYHAIV 10) In addition, the patient who judged an examination responsibility (allotment) doctor to be inappropriate as a subject

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
the change of the left ventricle function in the echocardiography
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath